{"id":"acoltremon-0-003","safety":{"commonSideEffects":[{"rate":null,"effect":"Ocular irritation"},{"rate":null,"effect":"Conjunctival hyperemia"},{"rate":null,"effect":"Transient vision blurring"}]},"_chembl":{"chemblId":"CHEMBL2441929","moleculeType":"Small molecule","molecularWeight":"289.42"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a retinoid compound applied topically at 0.003% concentration, acoltremon activates retinoid receptors in ocular tissues, which enhances epithelial cell differentiation and proliferation while reducing inflammatory responses. This mechanism supports corneal surface repair and may improve symptoms associated with dry eye disease or other anterior segment conditions.","oneSentence":"Acoltremon is a topical retinoid that modulates retinoid receptor signaling to promote corneal epithelial healing and reduce inflammation.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:17:17.846Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dry eye disease (marketed formulation)"}]},"trialDetails":[{"nctId":"NCT06544694","phase":"PHASE3","title":"A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2024-10-08","conditions":"Dry Eye Disease","enrollment":80},{"nctId":"NCT06660290","phase":"PHASE3","title":"A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2025-01-15","conditions":"Dry Eye Disease","enrollment":55},{"nctId":"NCT06544707","phase":"PHASE3","title":"A Study Designed to Evaluate Tear Production","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2024-10-15","conditions":"Dry Eye Disease","enrollment":81},{"nctId":"NCT07277257","phase":"PHASE4","title":"Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome","status":"RECRUITING","sponsor":"Center For Sight","startDate":"2025-12-02","conditions":"Sjogren Syndrome With Keratoconjunctivitis","enrollment":35},{"nctId":"NCT07281950","phase":"PHASE4","title":"Investigator Initiated Trial Using Dry Eye Surveys to Evaluate and Better Understand FDA Approved Acoltremon Treatment for Dry Eye Disease in Real World Treatment Settings (DESERT)","status":"NOT_YET_RECRUITING","sponsor":"Center for Sight Las Vegas","startDate":"2025-12-15","conditions":"Dry Eye Disease (DED)","enrollment":60},{"nctId":"NCT07268599","phase":"","title":"Moderate-to-Severe Dry Eye Disease Relief Using Acoltremon","status":"ENROLLING_BY_INVITATION","sponsor":"Colvard Kandavel Eye Center","startDate":"2025-11-24","conditions":"Dry Eye Disease (DED)","enrollment":50},{"nctId":"NCT07267299","phase":"PHASE4","title":"Switching From Restasis to TRYPTYR","status":"NOT_YET_RECRUITING","sponsor":"Southern College of Optometry","startDate":"2025-12-01","conditions":"Dry Eye, Eye Diseases, Chronic Dry Eye","enrollment":100},{"nctId":"NCT07267481","phase":"PHASE4","title":"Switching From Xiidra to TRYPTYR","status":"NOT_YET_RECRUITING","sponsor":"Southern College of Optometry","startDate":"2025-12-15","conditions":"Dry Eye, Dry Eyes Chronic, Dry Eye Syndromes","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"acoltremon 0.003%","genericName":"acoltremon 0.003%","companyName":"Center for Sight Las Vegas","companyId":"center-for-sight-las-vegas","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Acoltremon is a topical retinoid that modulates retinoid receptor signaling to promote corneal epithelial healing and reduce inflammation. Used for Dry eye disease (marketed formulation).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}